Lineage Cell Therapeutics Q1 EPS $(0.02) Beats $(0.03) Estimate, Sales $1.50M Miss $1.87M Estimate

Author: Benzinga Newsdesk | May 13, 2025 04:22pm
Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 50 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $1.50 million which missed the analyst consensus estimate of $1.87 million by 19.52 percent. This is a 4.02 percent increase over sales of $1.44 million the same period last year.

Posted In: LCTX